Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free ONCT Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Oncternal Therapeutics (ONCT) Short Interest Ratio & Short Volume

Oncternal Therapeutics logo
Compare

Oncternal Therapeutics Short Interest Overview

As of November 15, 2024, Oncternal Therapeutics (ONCT) had a short interest of 14,200 shares sold short, representing 0.54% of the public float. This marks a -68.72% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.1, meaning it would take 0.1 days of the average trading volume of 99,758 shares to cover all short positions.

Current Short Interest
14,200 shares
Previous Short Interest
45,400 shares
Change Vs. Previous Month
-68.72%
Dollar Volume Sold Short
$16.19 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
November 15, 2024
Outstanding Shares
2,960,000 shares
Float Size
2,650,000 shares
Short Percent of Float
0.54%
Today's Trading Volume
0 shares
Average Trading Volume
99,758 shares
Today's Volume Vs. Average
0%
Short Selling Oncternal Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Oncternal Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ONCT Short Interest Over Time

ONCT Days to Cover Over Time

ONCT Percentage of Float Shorted Over Time

Oncternal Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/202414,200 shares $16.19 thousand -68.7%0.5%0.1 $1.14
10/31/202445,400 shares $66.28 thousand +168.6%1.7%0.5 $1.46
10/15/202416,900 shares $20.45 thousand -5.6%0.6%0.2 $1.21
9/30/202417,900 shares $23.63 thousand -26.0%0.7%0.4 $1.32
9/15/202424,200 shares $35.33 thousand +79.3%0.9%0.8 $1.46
8/31/202413,500 shares $55.50 thousand -12.3%0.5%1.6 $4.11
8/15/202415,400 shares $58.52 thousand -12.0%0.6%1.8 $3.80
7/31/202417,500 shares $113.75 thousand -17.8%0.7%2.8 $6.50
7/15/202421,300 shares $163.37 thousand +4.4%0.8%3.7 $7.67
6/30/202420,400 shares $155.04 thousand +1.0%0.8%3.2 $7.60
6/15/202420,200 shares $177.44 thousand -3.4%0.8%3.4 $8.78
5/31/202420,900 shares $192.49 thousand -9.5%0.8%3.4 $9.21
5/15/202423,100 shares $204.20 thousand +77.7%0.9%3.3 $8.84
4/30/202413,000 shares $108.03 thousand -5.8%0.5%1.8 $8.31
4/15/202413,800 shares $121.44 thousand -17.4%0.5%1.5 $8.80
3/31/202416,700 shares $150.30 thousand +11.3%0.6%1.3 $9.00
3/15/202415,000 shares $120.30 thousand -6.3%0.6%1 $8.02
2/29/202416,000 shares $148.80 thousand -28.3%0.6%0.9 $9.30
2/15/202422,300 shares $200.48 thousand -10.8%0.8%1.3 $8.99
1/31/202425,000 shares $244.25 thousand +25.0%0.9%1.5 $9.77
1/15/202420,000 shares $171.80 thousand +52.7%0.8%1.2 $8.59
12/31/202313,100 shares $140.48 thousand -94.6%0.4%0.9 $10.72
12/15/2023241,400 shares $91.73 thousand -22.1%N/A1 $0.38
11/30/2023310,000 shares $114.08 thousand -28.6%N/A1.7 $0.37
11/15/2023433,900 shares $140.97 thousand +5.5%N/A2.9 $0.32
10/31/2023411,200 shares $139.56 thousand +46.7%N/A2.5 $0.34
10/15/2023280,300 shares $82.69 thousand +2.1%N/A1.7 $0.30
9/30/2023274,500 shares $82.35 thousand -8.0%N/A1.4 $0.30
9/15/2023298,300 shares $104.41 thousand +0.6%N/A1.4 $0.35
8/31/2023296,500 shares $88.95 thousand -7.6%N/A1.2 $0.30
8/15/2023320,900 shares $120.98 thousand -6.4%N/A1.2 $0.38
7/31/2023342,700 shares $126.90 thousand -23.6%N/A1.3 $0.37
7/15/2023448,600 shares $205.59 thousand +32.8%N/A1.7 $0.46
6/30/2023337,700 shares $116.51 thousand -4.0%N/A0.9 $0.35
6/15/2023351,600 shares $140.64 thousand +27.4%N/A0.6 $0.40
5/31/2023276,100 shares $78.69 thousand +7.4%N/A0.5 $0.29
5/15/2023257,000 shares $75.82 thousand -46.6%N/A0.5 $0.30
4/30/2023480,900 shares $147.40 thousand -1.9%N/A0.9 $0.31
4/15/2023490,300 shares $153.12 thousand +29.0%N/A1 $0.31
3/31/2023380,000 shares $298.30 thousand -8.0%N/A0.8 $0.79
3/15/2023412,900 shares $300.43 thousand +1.8%N/A1.8 $0.73
2/28/2023405,600 shares $361.63 thousand -2.1%N/A1.5 $0.89
2/15/2023414,200 shares $426.63 thousand -5.6%N/A1.6 $1.03
1/31/2023438,600 shares $491.23 thousand -34.3%N/A1.6 $1.12
1/15/2023667,600 shares $861.20 thousand -29.7%N/A2.4 $1.29
12/30/2022950,000 shares $950 thousand +0.2%N/A3.4 $1.00
12/15/2022947,800 shares $871.98 thousand +61.3%N/A3.4 $0.92
11/30/2022587,700 shares $534.87 thousand -18.2%N/A2.1 $0.91
11/15/2022718,800 shares $725.99 thousand +28.0%N/A2.8 $1.01
10/31/2022561,400 shares $589.47 thousand -15.6%N/A1.7 $1.05
10/15/2022665,300 shares $725.18 thousand -52.1%N/A1.8 $1.09
9/30/20221,390,000 shares $1.24 million +70.0%N/A3.3 $0.89
9/15/2022817,800 shares $801.53 thousand +38.2%1.7%1.6 $0.98
8/31/2022591,800 shares $662.82 thousand +7.4%1.3%1.1 $1.12
8/15/2022551,100 shares $677.85 thousand -16.3%1.3%0.5 $1.23
7/31/2022658,400 shares $678.15 thousand -1.9%1.5%0.6 $1.03
7/15/2022671,200 shares $771.88 thousand -11.1%1.5%0.6 $1.15
6/30/2022754,800 shares $837.83 thousand -66.2%8.5%0.7 $1.11
6/15/20222,230,000 shares $2.65 million -3.9%25.2%2.2 $1.19
5/31/20222,320,000 shares $3.43 million +14.3%5.4%2.6 $1.48
5/15/20222,030,000 shares $1.42 million -6.5%4.7%6.5 $0.70
4/30/20222,170,000 shares $1.85 million +4.3%5.0%7.3 $0.85
4/15/20222,080,000 shares $2.39 million +0.5%4.8%6.6 $1.15
3/31/20222,070,000 shares $2.88 million +0.5%4.8%5.7 $1.39
3/15/20222,060,000 shares $2.93 million +1.0%4.8%3.8 $1.42
2/28/20222,040,000 shares $3.73 million +0.5%4.7%3.5 $1.83
2/15/20222,030,000 shares $4.12 million -7.3%4.7%3.2 $2.03
1/31/20222,190,000 shares $4.10 million +6.3%5.5%3.2 $1.87
1/15/20222,060,000 shares $4.18 million +66.1%4.8%3 $2.03
12/31/20211,240,000 shares $2.81 million -6.8%2.9%1.9 $2.27
12/15/20211,330,000 shares $3.39 million -5.7%3.1%2.5 $2.55
11/30/20211,410,000 shares $4.16 million +6.8%3.2%2.8 $2.95
11/15/20211,320,000 shares $5.10 million -12.0%3.0%2.6 $3.86
10/29/20211,500,000 shares $5.51 million -3.9%3.5%2.8 $3.67
10/15/20211,560,000 shares $6.04 million -8.2%3.6%2.9 $3.87
9/30/20211,700,000 shares $7.09 million -11.5%3.9%2.7 $4.17
9/15/20211,920,000 shares $8.01 million -2.0%4.4%2.5 $4.17
8/31/20211,960,000 shares $8.86 million +15.3%4.5%2.4 $4.52
8/13/20211,700,000 shares $6.27 million -6.6%3.9%1.9 $3.69
7/30/20211,820,000 shares $7.10 million +0.6%4.2%1.8 $3.90
7/15/20211,810,000 shares $7.53 million -33.9%4.2%1.6 $4.16
6/30/20212,740,000 shares $13.02 million +115.8%6.3%2.3 $4.75
6/15/20211,270,000 shares $6.73 million +0.8%2.9%0.9 $5.30
5/28/20211,260,000 shares $7.17 million +17.8%2.9%0.8 $5.69
5/14/20211,070,000 shares $5.33 million +14.7%N/A0.7 $4.98

ONCT Short Interest - Frequently Asked Questions

Short interest is the volume of Oncternal Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 14,200 shares of ONCT short. 0.54% of Oncternal Therapeutics' shares are currently sold short. Learn More on Oncternal Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONCT shares currently have a short interest ratio of 0.1. Learn More on Oncternal Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.54% of Oncternal Therapeutics' floating shares are currently sold short.

Oncternal Therapeutics saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 14,200 shares, a decrease of 68.7% from the previous total of 45,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Oncternal Therapeutics currently has issued a total of 2,960,000 shares. Some of Oncternal Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncternal Therapeutics currently has a public float of 2,650,000 shares.

0.54% of Oncternal Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Oncternal Therapeutics: Gelteq Limited (0.53%), Mustang Bio, Inc. (1.39%), CNS Pharmaceuticals, Inc. (7.19%), Acurx Pharmaceuticals, Inc. (4.17%), Capstone Therapeutics Corp. (1.57%), Aptorum Group Limited (0.52%), Purple Biotech Ltd. Sponsored ADR (0.64%), Cardio Diagnostics Holdings, Inc. (2.10%), Flora Growth Corp. (2.22%), Redhill Biopharma Ltd. (0.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper Company ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), lululemon athletica inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), onsemi ($1.82 billion), and Tractor Supply Company ($1.65 billion). View all of the most shorted stocks.

Short selling ONCT is an investing strategy that aims to generate trading profit from Oncternal Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Oncternal Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONCT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONCT, twice per month. The most recent reporting period available is November, 15 2024.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ONCT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ONCT) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel